Of 83 HD patients, 33 (39.8%) had PHA-stimulated IFN-γ levels below 10, while14 (41.2%) of HD patients with LTBI and 19 (38.8%) non-LTBI HD patients, respectively, also had PHA-stimulated levels below 10 (Figure 3B). This evidence concerns the gene IFNG and Huntington disease.